Therapy Insight: Clinical management of pregnant women with epilepsy

Nature Clinical Practice Neurology

Volumn 2, Issue 4, 2006, Pages 190-200

  Pack, Alison M ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Antiepileptic drugs; Breastfeeding; Epilepsy malformations; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOCHROME P450; ETHOSUXIMIDE; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PHYTOMENADIONE; PRIMIDONE; TOPIRAMATE; TRIMETHADIONE; VALPROIC ACID; VITAMIN K GROUP; ZONISAMIDE;

BREAST FEEDING; BREAST MILK; CLEFT LIP PALATE; CLINICAL OBSERVATION; CLINICAL TRIAL; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; DEVELOPMENTAL DISORDER; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG METABOLISM; DRUG MONITORING; EPILEPSY; FEMALE; FETUS; FETUS DISEASE; FETUS HYPOXIA; FETUS MALFORMATION; GROWTH RETARDATION; HUMAN; HYPOPLASIA; INFANT; INGUINAL HERNIA; INTELLIGENCE QUOTIENT; KIDNEY MALFORMATION; LIMB MALFORMATION; LOW BIRTH WEIGHT; LUNG MALFORMATION; MATERNAL CARE; META ANALYSIS; MICROCEPHALY; MORBIDITY; NERVOUS SYSTEM MALFORMATION; NEURAL TUBE DEFECT; NEUROTOXICITY; NEWBORN HEMORRHAGIC DISEASE; PATIENT CARE; PATIENT COUNSELING; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; QUANTITATIVE ANALYSIS; REGISTER; RETROSPECTIVE STUDY; REVIEW; SEIZURE; STILLBIRTH; SYSTEMATIC REVIEW; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 33645377238     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0153     Document Type: Review

References (53)

1. Foldvary-Schaefer N et al. (2004) Hormones and seizures. Cleve Clin J Med 71 (Suppl 2): S11-S18
2. Pennell P (2005) Using current evidence in selecting antiepilepsy drugs for use during pregnancy. Epilepsy Curr 5: 45-51
3. Hallak M et al. (1999) Fetal rat brain damage caused by maternal seizure activity: Prevention by magnesium sulfate. Am J Obstet Gynecol 181: 828-834
4. Adab N et al. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75: 1575-1583
5. Nei M et al. (1998) A maternal complex partial seizure in labor can affect fetal heart rate. Neurology 51: 904-906
6. Sahoo S and Klein P (2005) Maternal complex partial seizure associated with fetal distress. Arch Neurol 62: 1304-1305
7. Vinten J et al. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64: 949-954
8. Speidel BD and Meadow SR (1972) Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 2: 839-843
9. Bjerkedal T and Bahna SL (1973) The course and outcome of pregnancy in women with epilepsy. Acta Obstet Gynecol Scand 52: 245-248
10. Olafsson E et al. (1998) Pregnancies of women with epilepsy: A population-based study in Iceland. Epilepsia 39: 887-892
11. Monson RR et al. (1973) Diphenylhydantoin and selected congenital malformations. N Engl J Med 289: 1049-1052
12. Hanson JW et al. (1976) Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89: 662-668
13. Holmes LB et al. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med 344: 1132-1138
14. Lindhout D et al. (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy paralleled by changes in pattern of malformations. Neurology 42 (Suppl 5): S94-S110
15. Nakane Y (1979) Congenital malformation among infants of epileptic mothers treated during pregnancy - the report of a collaborative study group in Japan. Folia Psychiatr Neurol Jpn 33: 363-369
16. Artama M et al. (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64: 1874-1878
17. Holmes LB et al. (2004) The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61: 673-678
18. Wyszynski DF et al. (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 84: 961-965
19. Vajda FJ et al. (2003) The Australian registry of anti-epileptic drugs in pregnancy: Experience after 30 months. J Clin Neurosci 10: 543-549
20. Vajda FJ et al. (2004) Critical relationship between sodium valproate dose and human teratogenicity: Results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 11: 854-858
21. Vajda F et al. (2004) Australian pregnancy registry of women taking antiepileptic drugs. Epilepsia 45: 1466
22. Vajda FJ and Eadie MJ (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112: 137-143
23. Morrow JI et al. (2005) Malformation risks of anti-epileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77: 193-198
24. Russell AJ et al. (2004) U.K. epilepsy and pregnancy group. Epilepsia 45: 1467
25. Tomson T et al. (2004) EURAP: An international registry of antiepileptic drugs and pregnancy. Epilepsia 45: 1463-1464
26. Cunnington M and Tennis P (2005) Lamotrigine and the risk of malformations in pregnancy. Neurology 64: 955-960
27. Matalon S et al. (2002) The teratogenic effect of carbamazepine: A meta-analysis of 1255 exposures. Reprod Toxicol 16: 9-17
28. Rosa FW (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324: 674-677
29. Hernandez-Diaz S et al. (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153: 961-968
30. Montouris G (2005) Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 21: 693-701
31. Montouris G (2003) Gabapentin exposure in human pregnancy: Results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4: 310-317
32. Long L (2003) Levetiracetam monotherapy during pregnancy: A case series. Epilepsy Behav 4: 447-448
33. Kondo T et al. (1996) Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia 37: 1242-1244
34. Pennell PB (2003) The importance of monotherapy in pregnancy. Neurology 60 (Suppl 4): S31-S38
35. Holmes LB et al. (2005) The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. J Pediatr 146: 118-122
36. Gaily E et al. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62: 28-32
37. Adab N et al. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70: 15-21
38. Reinisch JM et al. (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274: 1518-1525
39. Eriksson K et al. (2005) Children exposed to valproate in utero - population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65: 189-200
40. Meador K et al. (2005) Differential and dose dependent effects of in utero antiepileptic drugs [abstract #427]. Neurology 64 (Suppl 1): aS62.002
41. Bahado-Singh RO and Sutton-Riley J (2004) Biochemical screening for congenital defects. Obstet Gynecol Clin North Am 31: 857-872
42. Fong KW et al. (2004) Detection of fetal structural abnormalities with US during early pregnancy. Radiographics 24: 157-174
43. Pennell PB et al. (2004) The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 62: 292-295
44. Petrenaite V et al. (2005) Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res 65: 185-188
45. Choulika S et al. (2004) Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am J Obstet Gynecol 190: 882-883
46. Kaaja E et al. (2002) Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 58: 549-553
47. Astedt B (1995) Antenatal drugs affecting vitamin K status of the fetus and the newborn. Semin Thromb Hemost 21: 364-370
48. [No authors listed] (1998) Practice parameter: Management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology Epilepsia 39: 1226-1231
49. Pennell PB (2003) Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61 (Suppl 2): S35-S42
50. Liporace J et al. (2004) Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 5: 102-105
51. Johannessen SI et al. (2005) Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 46: 775-777
52. Ohman I et al. (2002) Topiramate kinetics during delivery, lactation, and in the neonate: Preliminary observations. Epilepsia 43: 1157-1160
53. Ohman I et al. (2005) Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: Does a fetal accumulation occur during pregnancy? Epilepsia 46: 1621-1624